HNB
MED icon

Huntington National Bank’s Medifast MED Stock Holding History

Huntington National Bank’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40
Closed -$547 – 4185
2025
Q3 		$547 Buy
+40
New +$559 ﹤0.01% 2382
2024
Q2 		– Sell
-82
Closed -$3.14K – 4141
2024
Q1 		$3.14K Buy
+82
New +$3.97K ﹤0.01% 2033
2023
Q3 		– Sell
-600
Closed -$55.3K – 3874
2023
Q2 		$55.3K Buy
+600
New +$53.4K ﹤0.01% 1007
2022
Q2 		– Sell
-3
Closed – – 2259
2022
Q1 		$0 Hold
3
– – ﹤0.01% 2221
2021
Q4 		$0 Hold
3
– – ﹤0.01% 2179
2021
Q3 		$0 Buy
+3
New +$737 ﹤0.01% 1922

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Huntington National Bank's MED Position: Q4 2025 in Review

Huntington National Bank sold out of Medifast (MED) in Q4 2025, closing a stake of 40 shares — an estimated $547 sold.

Huntington National Bank first reported a position in MED in Q3 2021 and held it in 6 quarters. The position peaked at $55.3K in Q2 2023. 109 funds tracked by Wall St. Rank hold MED as of Q4 2025.

  • Huntington National Bank reported no remaining Medifast position as of Q4 2025 after selling out during the quarter.
  • Huntington National Bank sold 40 Medifast shares in Q4 2025, an estimated $547.
  • Huntington National Bank first reported a position in Medifast in Q3 2021 and held it in 6 quarters.
  • Huntington National Bank's Medifast position peaked at $55.3K in Q2 2023.
  • 109 funds tracked by Wall St. Rank held Medifast as of Q4 2025.

Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.